T. Rowe Price Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $480K | Buy |
51,134
+7,228
| +16% | +$67.9K | ﹤0.01% | 2320 |
|
|
2025
Q1 | $313K | Buy |
43,906
+4,611
| +12% | +$32.9K | ﹤0.01% | 2453 |
|
|
2024
Q4 | $459K | Sell |
39,295
-543,237
| -93% | -$6.35M | ﹤0.01% | 2310 |
|
|
2024
Q3 | $12M | Sell |
582,532
-662,427
| -53% | -$13.6M | ﹤0.01% | 1106 |
|
|
2024
Q2 | $27.9M | Sell |
1,244,959
-380,092
| -23% | -$8.51M | ﹤0.01% | 871 |
|
|
2024
Q1 | $44.7M | Sell |
1,625,051
-209,092
| -11% | -$5.75M | 0.01% | 755 |
|
|
2023
Q4 | $55.9M | Sell |
1,834,143
-215,077
| -10% | -$6.56M | 0.01% | 676 |
|
|
2023
Q3 | $64.8M | Sell |
2,049,220
-11,271
| -0.5% | -$356K | 0.01% | 599 |
|
|
2023
Q2 | $84M | Buy |
2,060,491
+190,730
| +10% | +$7.78M | 0.01% | 563 |
|
|
2023
Q1 | $69.7M | Sell |
1,869,761
-59,594
| -3% | -$2.22M | 0.01% | 596 |
|
|
2022
Q4 | $67.3M | Buy |
1,929,355
+192,095
| +11% | +$6.7M | 0.01% | 583 |
|
|
2022
Q3 | $97.2M | Sell |
1,737,260
-310,071
| -15% | -$17.4M | 0.02% | 493 |
|
|
2022
Q2 | $106M | Sell |
2,047,331
-172,540
| -8% | -$8.93M | 0.01% | 639 |
|
|
2022
Q1 | $161M | Buy |
2,219,871
+119,523
| +6% | +$8.69M | 0.02% | 596 |
|
|
2021
Q4 | $248M | Sell |
2,100,348
-244,190
| -10% | -$28.9M | 0.02% | 500 |
|
|
2021
Q3 | $315M | Sell |
2,344,538
-141,953
| -6% | -$19M | 0.03% | 439 |
|
|
2021
Q2 | $403M | Buy |
2,486,491
+162,001
| +7% | +$26.2M | 0.04% | 383 |
|
|
2021
Q1 | $187M | Buy |
2,324,490
+203,607
| +10% | +$16.3M | 0.02% | 574 |
|
|
2020
Q4 | $115M | Buy |
2,120,883
+662,878
| +45% | +$36.1M | 0.01% | 679 |
|
|
2020
Q3 | $29M | Buy |
1,458,005
+104,691
| +8% | +$2.08M | ﹤0.01% | 1045 |
|
|
2020
Q2 | $28.4M | Buy |
+1,353,314
| New | +$28.4M | ﹤0.01% | 1037 |
|
|
2018
Q3 | – | Sell |
-10,222
| Closed | -$280K | – | 2583 |
|
|
2018
Q2 | $280K | Sell |
10,222
-48,718
| -83% | -$1.33M | ﹤0.01% | 2358 |
|
|
2018
Q1 | $1.24M | Buy |
+58,940
| New | +$1.24M | ﹤0.01% | 1702 |
|